Stella
November 16 - 17, 2017 - NC NC UMAllied Academies
vaccinesworld@alliedacademies.org
Phone:7025085200
Allided Academies Invites participants from all over the world to attend the “International Congress and Exhibition on Vaccines, Vaccination & Immunization, scheduled during November 16-17, 2017 at Vienna, Austria. Vaccines world-2017 Conference highlights the theme “To prevent the Resurgence of Vaccine Preventable Diseases”. Vaccines world -2017 is an event designed in a way to provide an exclusive platform for new researchers, scholars, physicians, Immunologists, students and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the concerned field. The two days of educational program will include keynote presentations, session speakers, and poster presenters on the latest in innovative techniques as well as papers in the areas of Vaccines, Immunology, Pathology, Advanced Delivery technologies in vaccines and Immunotherapy of deadly diseases like cancer. The global market for anti-counterfeiting packaging technologies is expected to increase from nearly$74.2 billion in 2015 to $135.6 billion in 2020, with a compound annual growth rate (CAGR) of 12.8% from 2015 to 2020. Influenza is a highly contagious viral disease. According to the report of World Health Organization, 15% of the world’s population get affected by this virus and cause a seasonal infection each year, leading to 250,000 to 500,000 deaths per year. Four Austrian companies including Baxter, Valneva, Marinomed Biotechnologie and Savira Pharmaceuticals are developing innovative ways to combat this debilitating viral infection and to prepare for possible future pandemics. In Vienna, Hookipa Biotech is focusing on vaccines and pre-clinical and clinical development activities. In October 2011, Hookipa raised €7 million funds from internationally renowned venture capital investors. Now they are focuses on the development of its lead vaccine candidate HB101 and plans to further industrialize the Vaxwave TM technology and build a robust pre-clinical product pipeline. Scientific Sessions: Novel Vaccines - Research and Development Vaccination for Viral Diseases Human Papillomavirus Infection Cancer Immunotherapy Vaccination for bacterial Diseases Infants/Children Vaccines Human Vaccines - Infectious & Non Infectious Diseases Vaccination for Pregnancy Vaccination for older/aged people Veterinary Vaccines Plant-Based Vaccines Clinical Trials in Animals Models Side Effects of Vaccines Vaccine Design-Immunoinformatics Advances in Vaccine Delivery Technologies Vaccination for Vector-borne Diseases To register online for the conference kindly go through the following link: http://vaccinesworld.alliedacademies.com/registration The Page will provide you all the details about the registration prices and packages.